LEVODOPA Next Previous

ChEMBL ID CHEMBL1009
PubChem CID 6047
DrugBank Accession Number DB01235
ClinicalTrials LEVODOPA
Molecular Formula C9H11NO4
Inchikey WTDRDQBEARUVNC-LURJTMIESA-N

Smiles
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O

Synonyms
levodopa, L-dopa, Dopar, 3,4-dihydroxy-L-phenylalanine, 59-92-7, 3-Hydroxy-L-tyrosine, Bendopa, Dopasol, Larodopa, Levopa, Cidandopa, Dopaidan, Dopalina, Insulamina, Maipedopa, Eldopal, Eldopar, Pardopa, Prodopa, Syndopa, Helfo-Dopa, Dopaflex, Dopaston, Doparl, (-)-Dopa, Dihydroxy-L-phenylalanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxyphenylalanine, Brocadopa, Doparkine, Dopastral, Eldopatec, Eurodopa, Levedopa, Deadopa, Doprin, Veldopa, Dopal-fher, Ledopa, Dopal, Weldopa, Parda, L-o-Hydroxytyrosine, Dopa, 3,4-Dihydroxyphenyl-L-alanine, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, L-Dihydroxyphenylalanine, Laradopa, Levodopum, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, L-3-Hydroxytyrosine, L-Tyrosine 3-hydroxy-, L-(-)-Dopa, Dopaston SE, L-(o-Dihydroxyphenyl)alanine, L-3,4-Dihydroxyphenylalanine, L-beta-(3,4-Dihydroxyphenyl)alanine, Biodopa, Cerepap, Sobiodopa, beta-(3,4-Dihydroxyphenyl)-L-alanine, beta-(3,4-Dihydroxyphenyl)alanine, L-3-(3,4-Dihydroxyphenyl)alanine, Helfo DOPA, L Dopa, Ro 4-6316, component of Sinemet, Dopar (TN), Tyrosine 3-hydroxy-, Dopastone, Dopicar, Levodopum [INN-Latin], CHEBI:15765, L(-)-Dopa, IV Levodopa, L-O-Dihydroxyphenylalanine, alanine 3-(3,4-dihydroxyphenyl)-, L-, (-)-(3,4-Dihydroxyphenyl)alanine, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, CHEMBL1009, Prestwick_185, CCRIS 3766, L-.beta.-(3,4-Dihydroxyphenyl)alanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, S1726_Selleck, HSDB 3348, Spectrum_000454, UNII-46627O600J, 3,4-Dihydroxyphenylalanine (VAN), Alanine 3-(3,4-dihydroxyphenyl)-, (-)-, AC1L1LOR, Prestwick0_000017, Prestwick1_000017, Prestwick2_000017, Prestwick3_000017, Spectrum2_000496, Spectrum4_000539, Spectrum5_001899, EINECS 200-445-2, Lopac-D-9628, dihydroxyphenylalanine, Levodopa (JP15/USP), NSC118381, bmse000322, NSC 118381, AC1Q4U7F, (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, CAS-59-92-7, 3 4-Dihydroxyphenylalanine, Lopac0_000454, BSPBio_000053, BSPBio_002354, KBioGR_001177, KBioSS_000934, L-4-5-Dihydroxyphenylalanine, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, BIDD:GT0158, Bio-0575, D9628_SIGMA, DivK1c_000452, SPBio_000391, SPBio_001974, SPECTRUM2300205, MLS000028514, BPBio1_000059, b-(3,4-Dihydroxyphenyl)alanine, 3 4-Dihydroxy-L-phenylalanine, 37830_FLUKA, HMS501G14, KBio1_000452, KBio2_000934, KBio2_003502, KBio2_006070, L-(3,4-Dihydroxyphenyl)alanine, Levodopa [USAN:INN:BAN:JAN], NINDS_000452, L-(3 4-Dihydroxyphenyl)alanine, WTDRDQBEARUVNC-LURJTMIESA-N, HMS1568C15, HMS1922J14, HMS2090O08, HMS2093N04, b-(3,4-Dihydroxyphenyl)-L-alanine, L-3-(3,4-dihydroxyphenyl)-Alanine, Alanine 3-(3,4-dihydroxyphenyl)-, LS-255, MFCD00002598, PDSP1_001541, PDSP2_001525, .beta.-(3,4-Dihydroxyphenyl)alanine, C9H11NO4, b-(3,4-Dihydroxyphenyl)-a-L-alanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, .beta.-(3 4-Dihydroxyphenyl)alanine, DB01235, SDCCGMLS-0066924.P001, IDI1_000452, NCGC00015384-01, NCGC00016270-01, NCGC00016270-04, NCGC00016270-06, NCGC00093869-04, SMR000058312, L-(3,4-Dihydroxyphenyl)-.alpha.-alanine, D0600, D9628, EU-0100454, Alanine 3-(3, 4-dihydroxyphenyl)-, (-)-, C00355, D 9628, D00059, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, 587-45-1, DAH, 1E83F927-C221-46AA-B90A-81B33C5F3868, 23734-74-9, 25525-15-9, 34241-25-3, 72572-99-7, 72573-00-3, 88250-23-1, 90638-38-3, L-DOPA Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa, L-3,4-Dihydrophenylalanine, WLN: QVYZ1R CQ DQ, Sinemetreg, Bidopal, CID6047, l)-L-alanine, L-DOPA; Levodopa, Madopa (Salt/Mix), nchembio.89-comp9, 3-(3,4-Dihydroxypheny, DSSTox_CID_3209, Epitope ID:150927, Alanine,4-dihydroxyphenyl)-, DSSTox_RID_76926, DSSTox_GSID_23209, SCHEMBL22655, L-Dopa L-3-Hydroxytyrosine, Levodopa (JP15/USP/INN), Levodopa (JP17/USP/INN), nchembio.2007.55-comp26, GTPL3639, (S)-3,4-dihydroxyphenylalanine, DTXSID9023209, WLN: QVYZ1R CQ DQ -L, CTK1H2187, HMDB00181, Alanine,4-dihydroxyphenyl)- L-, HMS2095C15, HMS2230B04, HMS3261K10, Pharmakon1600-0230020

Compound Properties
Drug/Drug-like Properties
Known Drug
Medchem Alerts
Passes of Rule of 3
Rule of 5 Violations 0
Molecular Species ZWITTERION
Molecular Properties
Molecular Weight 197.19
Rotatable Bonds 3
Acidic pKa (ACD) 2.24
Basic pKa (ACD) 8.85
LogP (ACD) -1.15
LogD (ACD) -3.67
ALogP -2.09
Loading...